Treatment

From Risk to Resilience: Preparing Healthcare Providers for the Psychedelic Therapy Revolution
Currently, MDMA-assisted therapy for PTSD and psilocybin for depression disorders await approval from the FDA. Meanwhile, practitioners are creating spaces...
One of the largest studies yet lends more evidence to the view that psilocybin "may hold promise as a novel...
My journey through 30 retreats made it quite clear that every center has a somewhat unique philosophy of care. With...
No fewer than 50 companies have shown interest in offering psychedelic therapy to their employees through healthcare plan startup Enthea....
The first-ever set of professional practice guidelines for psychedelic-assisted therapy were officially published today....
Psychedelic integration therapy is a powerful, essential tool that can maximize the therapeutic benefits of psychedelic experiences....
Kanna has gained popularity in recent years as a legal and non-psychedelic alternative to traditional psychedelics for anxiety and stress...
Australia has become the first country to prescribe MDMA to treat PTSD and psilocybin to combat treatment-resistant depression....
Ibogaine’s anti-addictive properties are known to work wonders on people struggling with various substances, such as cocaine, amphetamines, alcohol, nicotine...
New study brings hope to cancer patients struggling with depressive symptoms. Conflicts in Kentucky commission developing plan to fund research...